| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 05/21/2009 | US20090131326 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131324 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090130282 Kokumi Flavour Compounds and Use |
| 05/20/2009 | EP2059499A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom |
| 05/20/2009 | EP1270549B1 Polymer-immobilized alpha-iminoester |
| 05/20/2009 | CN101437801A Process for production of 4-oxoquinoline compound |
| 05/20/2009 | CN101437787A Method for preparing gabapentin |
| 05/20/2009 | CN101437785A Method for producing 4-oxoquinoline compound |
| 05/20/2009 | CN101437506A Compounds for the treatment of metabolic disorders |
| 05/20/2009 | CN101434572A Prodrugs of GABA analogs, compositions and uses thereof |
| 05/20/2009 | CN101434555A Method for synthesizing calcium glutamate |
| 05/20/2009 | CN101434554A Method for all-film extraction of aminoglutaric acid |
| 05/20/2009 | CN101434553A Method for all-film extraction of valine |
| 05/19/2009 | US7534915 Non-symmetrical gelling agent |
| 05/19/2009 | US7534914 Substituted methyl aryl or heteroaryl amide compounds |
| 05/19/2009 | US7534913 Crystalline form of nateglinide |
| 05/19/2009 | US7534813 2-(4-substituted phenoxy)ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate orally coadministered with a decarboxylase inhibitor or a catechol O-methyltransferase inhibitor; improved bioavailability when administered in the colon; sustained release; sleep disorders; nervous system disorders |
| 05/14/2009 | WO2009060886A1 Method for selectively reducing nitro group by metal catalyst-supported carbon |
| 05/14/2009 | US20090124820 C1-Symmetric Bisphospine Ligands and Their Use in the Asymmetric Synthesis of Pregabalin |
| 05/14/2009 | US20090123553 Peptide nanostructures and methods of generating and using the same |
| 05/13/2009 | EP2058298A2 Process of hydrocyanation of unsaturated carboxylic acid derivatives |
| 05/13/2009 | EP2057114A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 05/13/2009 | CN101431989A Arginine heteromers for topical administration |
| 05/13/2009 | CN101429133A Production process for recycling glutamic acid from high-dense high-mixture solution |
| 05/13/2009 | CN100486959C Combinational preparation method of nano zinc oxide and toluene dicarbamate |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531569 Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7530461 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/12/2009 | CA2349826C Process for the synthesis of 1-(aminomethyl)cyclohexyl-acetic acid |
| 05/07/2009 | WO2009058377A1 Ligands specific for cannabinoid receptor subtype 2 |
| 05/07/2009 | WO2009058299A1 P2x3 receptor antagonists for treatment of pain |
| 05/07/2009 | WO2009058298A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof |
| 05/07/2009 | WO2009037137A3 Process from shikimic acid to oseltamivir phosphate |
| 05/07/2009 | WO2009035535A3 Method of crystallizing carvedilol phosphate and the product thereof |
| 05/07/2009 | WO2009016235A3 Chelating agent based ionic liquids, a process to prepare them, and their use |
| 05/07/2009 | WO2008145225A3 Photocrosslinkable materials comprising alicyclic group |
| 05/07/2009 | US20090118368 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 05/07/2009 | US20090118366 Organic compounds |
| 05/07/2009 | US20090118199 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090114879 Additive for preserving the fluidity of fluids containing gas hydrates |
| 05/06/2009 | EP2054375A2 Process of preparing a gamma-amino acid |
| 05/06/2009 | CN100484914C 1-carbamoylcycloalkylcarboxylic acid compounds, processes fro making and uses thereof |
| 05/05/2009 | US7528276 Process for preparing the intermediate compounds for PPAR α ligands |
| 05/05/2009 | US7528260 Method for preparing N-phenylpyrazole-1-carboxamides |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009054545A1 Liquid crystal aligning agent, method for forming liquid crystal alignment film and liquid crystal display device |
| 04/30/2009 | WO2009004643A3 An improved process for preparation of (s)-pregabalin and intermediates thereof |
| 04/30/2009 | US20090111983 Cycloalkylcarbonylamino Acid Derivative and Process For Producing The Same |
| 04/30/2009 | US20090111874 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 04/30/2009 | US20090111813 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/30/2009 | US20090110796 Aromatic neomenthylamides as flavoring substances |
| 04/29/2009 | EP2053039A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 04/29/2009 | EP2051959A1 A novel process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid ester |
| 04/29/2009 | EP2051958A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | CN101417959A Synthesis method of L-p-nitrophenylalanine |
| 04/29/2009 | CN101417958A Method for extracting high quality, low material consumption and low waste water glutamic acid |
| 04/29/2009 | CN100482637C Compounds and compositions for delivering active agents |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/29/2009 | CN100482626C Novel atisane compound and use thereof |
| 04/28/2009 | US7524925 Protein interaction reporter agents and methods for using same |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | CA2486883C Method of manufacturing sertindole |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009052341A1 Gsm intermediates |
| 04/23/2009 | WO2009050041A1 Novel carbamoylglycine derivatives |
| 04/23/2009 | WO2009018389A4 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/23/2009 | WO2006047740A3 Heat shock protein 90 inhibitors |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105352 Functionalized biodegradable triclosan monomers and oligomers for controlled release |
| 04/23/2009 | US20090105337 Esters of Florfenicol |
| 04/23/2009 | US20090105328 Amino Acid Compounds |
| 04/23/2009 | US20090105300 AMINE LINKED MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105238 Compounds and Relative use for the Control of Phytopathogens |
| 04/23/2009 | US20090105237 Cooling compounds |
| 04/23/2009 | US20090105091 Modified Amino Acids |
| 04/23/2009 | DE112004001191T5 Aztreonam L-Lysin und Verfahren für dessen Herstellung Aztreonam L-lysine and method for its preparation |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702911A1 Gsm intermediates |
| 04/22/2009 | EP2050738A1 Novel imidazolidinone derivative, method of producing the same and method of producing optically active amino acid |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | CN101412682A Process for synthesizing aryl anthranilic acid and derivatives thereof |
| 04/22/2009 | CN100480233C Method for producing phenylalanine derivative and synthetic intermediate thereof |
| 04/21/2009 | US7521577 Cell biology, neurology, nutrition, immunology, reproductive biology, cancer and proteomics; facilitate binding, detecting, monitoring and quantitating of heavy metalnovel luminescence-based materials ; |
| 04/21/2009 | US7521566 N-[(S)-1-carbethoxybutyl]-(S)-alanine carboxylic acid halide is reacted with benzyl ester of (2S, 3aS, 7aS)-2-carboxyperhydroindole, followed by catalytic hydrogenation to give perindopril |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009047446A2 Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid |
| 04/16/2009 | WO2009047245A1 Method for preparing polymer materials doped with metal elements and resulting materials |
| 04/16/2009 | WO2008035222A3 Synthesis of carbohydrate-templated amino acids and methods of using same |